Showing results (291-300 of 486) with videos related to
Sort By:
Pageof 49
Vaccines|July 27, 2022
Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare WorkersThomas Theo Brehm, Felix Ullrich, Michelle Thompson, et al.Plos One|October 11, 2016
Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing CholangitisHanno Ehlken, Raluca Wroblewski, Christophe Corpechot, et al.European Journal of Immunology|February 21, 2019
CCL21-expression and accumulation of CCR7+ NK cells in livers of patients with primary sclerosing cholangitisAnnika E Langeneckert, Sebastian Lunemann, Glòria Martrus, et al.Journal of Hepatology|January 15, 2019
Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitisTobias Schmidt, Dorothee Schwinge, Tim Rolvien, et al.Scientific Reports|January 11, 2018
Flt3 ligand expands bona fide innate lymphoid cell precursors in vivoSara M Parigi, Paulo Czarnewski, Srustidhar Das, et al.Oncoimmunology|August 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patientsJoao Gorgulho, Timo Trenkner, Eva Kinkel, et al.Alimentary Pharmacology & Therapeutics|October 21, 2022
A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitisTimur Liwinski, Sina Hübener, Lara Henze, et al.Hepatology (Baltimore, Md.)|October 13, 2017
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitisKris V Kowdley, Velimir Luketic, Roger Chapman, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2022
Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitisJohannes Hartl, Darius Ferenc Rüther, Paul Maria Duengelhoef, et al.JHEP Reports : Innovation in Hepatology|July 17, 2023
Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver diseaseKalliopi Zachou, Kalliopi Azariadis, Ellina Lytvyak, et al.Pageof 49